Stifel Nicolaus analyst Valentin Paul Jahan maintained a Buy rating on VETOQUINOL (0O1O – Research Report) today and set a price target of €120.00.
Valentin Paul Jahan has given his Buy rating due to a combination of factors that suggest a promising outlook for VETOQUINOL. The company has shown a return to growth in its adjusted EBIT for the first time in three years, indicating a positive shift in its financial performance. This improvement is expected to continue, driven by the repositioning of its product portfolio and a high gross margin, which positions the company well for accelerated earnings per share growth.
Moreover, VETOQUINOL’s current low valuation multiple presents a significant discount compared to its peers and historical averages. This undervaluation, coupled with the company’s strong financial fundamentals and growth prospects, offers a compelling investment opportunity. The anticipated acceleration in sales and earnings growth, particularly in the U.S. market, further supports the Buy rating, as it is likely to lead to a solid re-rating potential in the future.